Key Financial Data Of Reporting Company

Perseus Proteomics Inc. - Filing #7296856

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
59,390,000 JPY
100,402,000 JPY
50,937,000 JPY
Ordinary profit (loss)
-427,243,000 JPY
-879,380,000 JPY
-429,084,000 JPY
Profit (loss)
-495,433,000 JPY
-1,104,460,000 JPY
-633,487,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
2,436,148,000 JPY
1,971,019,000 JPY
1,939,252,000 JPY
Total number of issued shares
14,740,500 xbrli:shares
11,936,400 xbrli:shares
11,759,400 xbrli:shares
Net assets
1,838,254,000 JPY
1,398,344,000 JPY
1,783,942,000 JPY
Total assets
2,191,325,000 JPY
1,693,810,000 JPY
1,989,786,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-35.90
-93.69
-53.87
Diluted earnings per share
Equity-to-asset ratio
0.8027 xbrli:pure
0.7818 xbrli:pure
0.8703 xbrli:pure
Net cash provided by (used in) operating activities
-312,460,000 JPY
-833,898,000 JPY
-464,745,000 JPY
Net cash provided by (used in) investing activities
-52,089,000 JPY
-150,343,000 JPY
-129,402,000 JPY
Net cash provided by (used in) financing activities
919,892,000 JPY
63,943,000 JPY
JPY
Cash and cash equivalents
2,086,449,000 JPY
1,541,419,000 JPY
1,866,008,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.